Stocks and Investing Stocks and Investing
Tue, January 7, 2025
[ 09:41 AM ] - MSN
Build a Bulletproof Portfolio with These Three Diversified Dividend Stocks
[ 09:21 AM ] - MSN
UK sees surge in crypto ownership with 7 million Brits investing in digital assets
[ 08:01 AM ] - Sky
Money blog: High street chain with 364 stores 'accelerating closures' due to budget
[ 07:01 AM ] - MSN
Top 3 Contra Mutual Funds With Best SIP Returns i .. nvestment in No. 1 fund is now worth Rs 12,00,878
[ 06:41 AM ] - MSN
Here's Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10
[ 06:41 AM ] - MSN
Should The Coca-Cola Company (NYSE:KO) Be In Your Early Retirement Portfolio?
[ 06:21 AM ] - MarketWatch
10 financial advisers on their No. 1 piece of money advice for 2025
[ 05:41 AM ] - MSN
Watch out, this UK stock's already jumped out of the blocks for 2025!
[ 05:21 AM ] - MSN
Warren Buffett's Warning to Wall Street Reached D .. in 2024. Here's What to Do as 2025 Gets Started.
[ 01:21 AM ] - Forbes
Angel One Review 2025: Features, Pros & Cons
[ 01:01 AM ] - MSN
Investors Look Back at 2024
[ 12:01 AM ] - MarketWatch
Stock Market Today: Dow ends lower while Nasdaq logs best start to a year since 2009
Mon, January 6, 2025
[ 11:41 PM ] - MSN
Best small cap mutual funds to invest in January 2025
[ 10:01 PM ] - MSN
Invest $30,000 in 2 TSX Stocks and Create $611.52 in Dividend Income
[ 09:41 PM ] - MSN
Here's How Much 35-Year-Old Canadians Need Now to Retire at 65
[ 09:01 PM ] - MSN
Here's Why Paycor HCM Inc. (NASDAQ:PYCR) Is Skyrocketing
[ 08:41 PM ] - esquiremag
Financial Adviser: 5 Investing Resolutions for 2025 and How to Achieve Them
[ 07:41 PM ] - MSN
The CRA Is Watching: TFSA Investors Should Avoid These Red Flags
[ 07:41 PM ] - MSN
What are Intrusion-related Gold Systems?
[ 07:01 PM ] - MSN
Here's Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10
[ 04:41 PM ] - MSN
Is Trip.com Group Limited (TCOM) One of the Best Travel Stocks to Buy Right Now?
[ 04:01 PM ] - MSN
How Should a Beginner Invest in Stocks? Start With This Index Fund
[ 02:21 PM ] - MSN
This Quantum Computing Stock Is About to Set New Record Highs. Is It a Buy for 2025?
[ 02:01 PM ] - MSN
Globalfoundries Inc. (NASDAQ:GFS): Powering AI In .. tion with Advanced 22FDX Semiconductor Technology
[ 01:21 PM ] - MoneySense
For 2025, experts predict economic growth, but slower gains and more volatility
[ 11:01 AM ] - MSN
Why Is Barclays PLC (NYSE:BCS) Among the Best FTSE Dividend Stocks to Buy Now?
[ 11:01 AM ] - MSN
Want $10 Million in Retirement? 1 Easy ETF to Buy and Hold for Decades.
[ 10:50 AM ] - WOPRAI
5 Earnings Releases for 2025, Jan 06th
[ 10:21 AM ] - MSN
Is Apollo Global Management Inc. (NYSE:APO) Among .. el Englander's Top Stock Picks Heading Into 2025?
[ 09:41 AM ] - MSN
Here's Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10

Here's Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10


Published on 2025-01-06 09:41:13 - MSN
  Print publication without navigation

  • We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at where NeuroMetrix, Inc. (NASDAQ:NURO) stands against the other diabetes stocks.

The article from MSN Money discusses why NeuroMetrix Inc. (NASDAQ: NURO) is considered one of the best diabetes stocks to buy under $10. NeuroMetrix focuses on developing and commercializing medical devices for the management of chronic pain, neurological, and cardiovascular conditions, which indirectly relates to diabetes management through its Quell wearable pain relief device. The company's stock is highlighted for its potential due to several factors: its low market cap, which makes it an attractive option for investors looking for growth opportunities; the increasing prevalence of diabetes globally, which could drive demand for related health management solutions; and the company's efforts to expand its product offerings and market reach. Additionally, NeuroMetrix has shown promising developments in its technology, aiming to address the needs of diabetic patients who often suffer from neuropathic pain. The article suggests that these elements combined make NeuroMetrix an appealing investment in the diabetes care sector.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/here-s-why-neurometrix-inc-nasdaq-nuro-is-among-the-best-diabetes-stocks-to-buy-under-10/ar-AA1x2N20 ]
Contributing Sources